This webinar will address:
• New FDA Approval • Foot and Ankle Studies
Kerecis®️, the company pioneering the use of fish skin and fatty acids in cellular therapy, tissue regeneration and protection, has received authorization from the FDA to market Kerecis Omega3 SurgiBind™️. The product, which is available now in the United States, is an implantable fish-skin graft for use in plastic and reconstructive surgery. The product is indicated for implantation to reinforce soft tissue where weakness exists, in patients requiring soft tissue repair, or reinforcement in plastic or reconstructive surgery.
Host: Dr. Lee Rogers
Speakers:
Dr. Patrick McEneaney – Medical Director & Principal Investigator of the Northern Illinois Foot & Ankle Specialists Northern Illinois Foot & Ankle Specialists
Dr. Pete Lovato – Doctor of Podiatric Medicine Centegra Hospitals and Advocate Sherman Hospital
Date and Time: Dec 16, 2021, 09:00 PM in Eastern Time (US and Canada)
